CSRXP APPLAUDS USPTO EFFORTS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE AND SUPPORTS ADDITIONAL SOLUTIONS TO BOOST COMPETITION TO HELP LOWER DRUG PRICES
Comment Letters Highlight Key Agency Initiatives Targeting Brand Name Drug… Read More
Comment Letters Highlight Key Agency Initiatives Targeting Brand Name Drug… Read More
Non-Profit Advocates for Affordable Prescription Drug Prices Call on Congress… Read More
New Matrix Global Advisors Report Shines Light on Cost of Big Pharma’s… Read More
Broad Majorities Reject Big Pharma’s Blame Game and Want Policymakers to… Read More
Brand Name Drug Companies Increase Prices on Treatments for Serious Conditions… Read More
Brand Name Drug Companies Continue Seeking to Price-Gouge COVID-19 Treatments… Read More
Analysis Finds Drug Companies Increased Prices Faster Than the Rate of… Read More
Brand Name Drug Companies Setting Egregious Prices on New Products Not… Read More
Congressional Probe Concludes Biogen Set Egregious Price Tag on Aduhelm to… Read More
Brand Name Drug Companies Maintain Business-as-Usual Approach to Price-Gouging… Read More
Get the Facts on Big Pharma’s Year of Out-of-Control Launch Prices… Read More
Amgen and Horizon Therapeutics Eye Merger As Both Continue to Hike Prices on… Read More